Safety and IOP-Lowering Effects of WB007

Conditions:   Glaucoma, Primary Open Angle;   Ocular Hypertension Interventions:   Drug: Study Treatment 1 WB007;   Drug: Study Treatment 2 WB007;   Drug: Study Treatment 3 WB007;   Drug: Timolol 0.5% Sponsor:   Whitecap Biosciences, LLC Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials